Replies to post #473405 on NorthWest Biotherapeutics Inc (NWBO)

[Kkhors]

Wasn’t the purpose of our medical journal publication to avoid this? Great plan another poor execution by NWBO Management!!!!

[Margin Buu]

oversimplification, misinterpretation, and omission

Exactly. Wonder who directed the note-maker to omit that this was the first statistically significant extension in overall survival (the gold standard) for GBM treatment in over 25 years?

Do the people working at the AACR what pseudo-progression is? Do they care that the fact that there was pseudo-progression proves the vaccine was working and there was a tumor response? It's clear that there's extreme bias written in that note down to the words they decided to bold.

[Horseb4CarT]

I would like to see the information flow for how that specific blurb wound up in this news flash section of this aacr journal?

Very poor reporting to report one’s own incorrect interpretation of what was presented, and not report at all the primary and secondary endpoints being met!

Who did the journal receive this blurb from and who reviewed and edited it? Where’s the due diligence and verification, especially when the presentation conclusions are nothing but strongly positive?

This will be corrected when the paper and official TLD are out but this misreporting is damaging in the meantime.

Imo it suggests incompetence at a minimum and flaw or exploitation of the reporting process used.